FDA Approves Zepbound®: A Groundbreaking Treatment for Obstructive Sleep Apnea and Obesity
Introduction On 20 December 2024, the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first prescription medicine
Introduction On 20 December 2024, the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first prescription medicine
The origins of Covid-19 have been a source of intense debate since the virus emerged in 2019. A new claim
California has taken swift action in response to a severe bird flu case, declaring a state of emergency to contain